Spica Therapeutics
Latest round
- Seed
Last raised
- Jun 2025
Total raised
- $4.4M
Investors
- 3
About Spica Therapeutics
Founded in 2024 and based in Aarhus, Denmark, Spica Therapeutics operates as a biotechnology company that provides therapies for oncology and autoimmune illnesses. The firm was co-founded by Anders Etzerodt (CSO), Jonas H. Graversen (Site Head), Toby Lawrence, Holger J. Møller, and Søren K. Moestrup. Therapeutics utilizes its proprietary functional macrophage fingerprinting technology to identify and selectively target disease-relevant macrophage subsets. The firm's technology address significant unmet medical needs in therapeutic areas such as oncology, fibroinflammatory, and autoimmune diseases. The company is advancing two lead programs specifically tailored for oncology and fibroinflammatory conditions, utilizing methodologies derived from research at prominent institutions in Europe. The products developed are intended for healthcare providers and researchers engaged in the treatment and study of these complex diseases.
Who invested in Spica Therapeutics
3 investors across 2 rounds
See all investors in Spica Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Spica Therapeutics
Who invested in Spica Therapeutics?
Spica Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spica Therapeutics raised?
Spica Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Spica Therapeutics last raise money?
Spica Therapeutics's most recent round on record is a Seed, in Jun 2025.
What does Spica Therapeutics do?
Founded in 2024 and based in Aarhus, Denmark, Spica Therapeutics operates as a biotechnology company that provides therapies for oncology and autoimmune illnesses.
Where is Spica Therapeutics headquartered?
Spica Therapeutics is headquartered in Brussels, Belgium.
Which VCs invest in companies like Spica Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Spica Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Spica Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.